These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2395003)

  • 61. Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody.
    Kikuchi T; Watanabe M; Ohno T
    Jpn J Cancer Res; 1991 Mar; 82(3):339-45. PubMed ID: 1827092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphokine-activated killer cell activity after cryopreservation.
    Schmidt-Wolf IG; Aihara M; Negrin RS; Blume KG; Chao NJ
    J Immunol Methods; 1989 Dec; 125(1-2):185-9. PubMed ID: 2607152
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assay of lymphokine-activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia.
    Zhou MX; Findley HW; Davis R; Ragab AH
    Blood; 1990 Jan; 75(1):160-5. PubMed ID: 2294987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The precursors and effectors of human lymphokine-activated killer (LAK) cells].
    Guo X
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):266-9, 317-8. PubMed ID: 8221242
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
    Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
    Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interleukin-2-activated lymphocytes from brain tumor patients. A comparison of two preparations generated in vitro.
    Kruse CA; Mitchell DH; Lillehei KO; Johnson SD; McCleary EL; Moore GE; Waldrop S; Mierau GW
    Cancer; 1989 Oct; 64(8):1629-37. PubMed ID: 2790675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of OK-432 on the proliferation and cytotoxicity of lymphokine-activated killer (LAK) cells.
    Yamamoto K; Tanaka R; Yoshida S; Ono K; Mori H; Taniguchi Y; Oda T; Watanabe T
    J Immunother; 1999 Jan; 22(1):33-40. PubMed ID: 9924697
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.
    Ebihara T; Fukao K; Koyama S
    Cancer; 1990 Sep; 66(5):923-9. PubMed ID: 2167147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct characteristics of lymphokine-activated killer (LAK) cells derived from patients with B-cell chronic lymphocytic leukemia (B-CLL). A factor in B-CLL serum promotes natural killer cell-like LAK cell growth.
    Santiago-Schwarz F; Panagiotopoulos C; Sawitsky A; Rai KR
    Blood; 1990 Oct; 76(7):1355-60. PubMed ID: 2207313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymphokine-activated killer-cell-mediated killing of WiDr colon carcinoma cells is inhibited by K562 erythroleukemia cells.
    Dullens HF; Wind JC; Maas RA; Bernsen MR; Vulto IM; Rademakers LH; Den Otter W
    Int Immunol; 1991 Oct; 3(10):959-64. PubMed ID: 1756146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The influence of cryopreservation on activity and surface markers of lymphokine-activated killer cells.
    Letellier C; Rameliarison L; Fizet D; Ferrer AM; Vezon G
    Vox Sang; 1991; 61(2):90-5. PubMed ID: 1763504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.
    Koyama S; Ebihara T; Fukao K; Osuga T
    Jpn J Cancer Res; 1989 Feb; 80(2):150-7. PubMed ID: 2498249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low molecular weight B-cell growth factor and recombinant interleukin-2 are together able to generate cytotoxic T lymphocytes with LAK activity from the bone marrow cells of children with acute lymphoblastic leukemia.
    Zhou MX; Findley HW; Ragab AH
    Blood; 1989 Sep; 74(4):1355-9. PubMed ID: 2788465
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-2 (rIL-2)-induced lymphokine-activated killer (LAK) cells and their precursors express the VGO1 antigen.
    Denegri JF; Peterson J; Tilley P
    J Clin Immunol; 1989 Jul; 9(4):362-7. PubMed ID: 2788659
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of interleukin 4 upon human tumoricidal cells obtained from patients bearing solid tumors.
    Jadus MR; Good RW; Crumpacker DB; Yannelli JR
    J Leukoc Biol; 1991 Feb; 49(2):139-51. PubMed ID: 1991997
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The augmentation of lymphokine-activated killer cell activity by indomethacin in vitro is not mediated by prostaglandin E2 suppression.
    Chao TY; Ting CS; Chu TM; Yeh MY
    Proc Natl Sci Counc Repub China B; 1993 Oct; 17(4):138-42. PubMed ID: 8171164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytotoxic events taking place in the lung of patients with HIV-1 infection. Evidence of an intrinsic defect of the major histocompatibility complex-unrestricted killing partially restored by the incubation with rIL-2.
    Agostini C; Zambello R; Trentin L; Feruglio C; Masciarelli M; Siviero F; Poletti V; Spiga L; Gritti F; Semenzato G
    Am Rev Respir Dis; 1990 Sep; 142(3):516-22. PubMed ID: 2389902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans.
    Eberlein TJ; Rodrick ML; Massaro AF; Jung SE; Mannick JA; Schoof DD
    Cancer Immunol Immunother; 1989; 30(3):145-50. PubMed ID: 2598183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proliferation and cytotoxicity of lectin-induced lymphokine-activated killer (LILAK) cells.
    Shimizu Y; Kuroki T; Shiomi S; Kobayashi K; Monna T
    J Gastroenterol Hepatol; 1991; 6(5):485-90. PubMed ID: 1657242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lysis of human alveolar macrophages by lymphokine-activated killer cells.
    Maruyama M; Kawasaki A; Suzuki H; Yamashita N; Yano S
    Chest; 1990 Jun; 97(6):1372-6. PubMed ID: 2347221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.